Editorial for the Special Issue on “Human Biomonitoring in Health Risk Assessment: Current Practices and Recommendations for the Future” - Anses - Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail Accéder directement au contenu
Article Dans Une Revue Toxics Année : 2023

Editorial for the Special Issue on “Human Biomonitoring in Health Risk Assessment: Current Practices and Recommendations for the Future”

Christophe Rousselle

Résumé

In most health risk assessment (HRA) frameworks for chemicals, the default approach for exposure assessment is to estimate the intake from different sources and different routes of exposure. These assessments are often made separately and then added when aggregate exposure scenarios are considered. Various uncertainties are associated with this approach and, depending on the scope of the assessment; it may over- or under-estimate the internal exposure. Having access to data on the internal exposure generated by human biomonitoring gives a complete picture of human exposure and can be used to enhance a chemical risk assessment by providing information on actual human exposure via multiple exposure pathways. An understanding of the contribution that different exposure routes make to the overall exposure (taking into account differences in exposure modifiers, such as age and gender, as well as profession) delivers a starting point for deciding on risk management measures under legislative silos.
Fichier principal
Vignette du fichier
toxics-11-00168.pdf (205.9 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

anses-03996674 , version 1 (20-02-2023)

Identifiants

Citer

Christophe Rousselle. Editorial for the Special Issue on “Human Biomonitoring in Health Risk Assessment: Current Practices and Recommendations for the Future”. Toxics, 2023, 11 (2), pp.168. ⟨10.3390/toxics11020168⟩. ⟨anses-03996674⟩

Collections

ANSES
12 Consultations
16 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More